Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-59 of 59 for Chronic lymphoid leukemia

Edit search filters
  1. Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

    Rochester, MN

  2. Epidemiology of Chronic Lymphocytic Leukemia

    Rochester, MN

  3. informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

    Jacksonville, FL

  4. Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Study to Assess the Safety and Effectiveness of Shingrix Vaccine in Patients with Hematologic Malignancies

    Rochester, MN

  6. Symptomatic Assessment in Patients with Chronic Hematologic Malignancies

    Scottsdale/Phoenix, AZ

  7. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions

    Rochester, MN

  8. Analysis of Immunostaining during Mohs Micrographic Surgery to Improve Detection of Negative Surgical Margins in Patients with Squamous Cell Carcinoma and Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL)

    Rochester, MN

  9. Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and Associated Precursors

    Rochester, MN

.

Mayo Clinic Footer